83 related articles for article (PubMed ID: 582538)
1. Pharmacological properties of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Mir GN; Sperow JW; Riley RL; Alioto RL; Nuss GW; Chou BJ; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1466-70. PubMed ID: 582538
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Mir GN; Sperow JW; Krebs JB; Eash JR; Rowles GS; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1454-61. PubMed ID: 89850
[TBL] [Abstract][Full Text] [Related]
3. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide.
Mir GN; Alioto RL; Sperow JW; Eash JR; Krebs JB; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1448-54. PubMed ID: 582536
[TBL] [Abstract][Full Text] [Related]
4. Effects of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent on the cardiovascular and central nervous systems.
Riley RL; Mir GN; Rowles GS; Sperow JW; Alioto RL; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1461-6. PubMed ID: 582537
[TBL] [Abstract][Full Text] [Related]
5. Toxicity studies on lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Chou BJ; Mir GN; Brown WR; Rapp WR; Yelnosky J
Arzneimittelforschung; 1978; 28(8a):1471-6. PubMed ID: 113015
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey.
DeLong AF; Martin GP; Polk A; Carter V; Herczeg T
Arzneimittelforschung; 1978; 28(8a):1477-80. PubMed ID: 113016
[TBL] [Abstract][Full Text] [Related]
7. Analytical-physical profile of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent.
Zalipsky JJ; Won CM; Patel DM
Arzneimittelforschung; 1978; 28(8a):1441-7. PubMed ID: 582535
[TBL] [Abstract][Full Text] [Related]
8. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats.
Eaker EY; Bixler GB; Mathias JR
J Pharmacol Exp Ther; 1988 Aug; 246(2):786-9. PubMed ID: 3404458
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the safety and effectiveness of WHR-1142A in the treatment of non-specific acute diarrhea].
Heredia Díaz JG; Alcántara I; Solís A
Rev Gastroenterol Mex; 1979; 44(4):167-73. PubMed ID: 394268
[TBL] [Abstract][Full Text] [Related]
10. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological studies on droxicainide, a new antiarrhythmic agent.
Aberg G; af Ekenstam B; Smith E
Arzneimittelforschung; 1983; 33(5):706-10. PubMed ID: 6683549
[TBL] [Abstract][Full Text] [Related]
12. General pharmacological profile of the new cognition-enhancing agent nefiracetam.
Kitano Y; Makino M; Usui C; Takasuna K; Kasai Y; Hirohashi M; Tamura K; Takayama S; Kojima H; Iizuka H
Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090
[TBL] [Abstract][Full Text] [Related]
13. General pharmacology of the new antimuscarinic compound vamicamide.
Yamamoto T; Honbo T; Tokoro K; Kojimoto Y; Kodama R; Ohtsuka M; Shimomura K
Arzneimittelforschung; 1995 Dec; 45(12):1274-84. PubMed ID: 8595084
[TBL] [Abstract][Full Text] [Related]
14. General pharmacology of loracarbef in animals.
Shetler T; Bendele A; Buening M; Clemens J; Colbert W; Deldar A; Helton D; McGrath J; Shannon H; Turk J
Arzneimittelforschung; 1993 Jan; 43(1):60-70. PubMed ID: 8447851
[TBL] [Abstract][Full Text] [Related]
15. Absence of mutagenic activity of WHR-1142A, lidamidine hydrochloride, in 4 short-term tests for mutagenic/carcinogenic potential.
Allen JA; Jones E; Richardson JC; Richold M
Mutat Res; 1983 Mar; 116(3-4):399-405. PubMed ID: 6339900
[TBL] [Abstract][Full Text] [Related]
16. General pharmacological properties of the new vasodilator flosequinan.
Ikezono K; Fujita S; Umezato M; Hosoki E; Toba Y; Kusunoki A; Shintani S
Arzneimittelforschung; 1992 Oct; 42(10):1200-11. PubMed ID: 1472141
[TBL] [Abstract][Full Text] [Related]
17. General pharmacological profile of the new anti-ulcer drug 3-[[[2-(3,4-dimethoxyphenyl)ethyl]carbamoyl]methyl]-amino-N -methylbenzamide.
Hirohashi M; Takasuna K; Kasai Y; Usui C; Tamura K; Kojima H
Arzneimittelforschung; 1993 May; 43(5):569-77. PubMed ID: 8329002
[TBL] [Abstract][Full Text] [Related]
18. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
[TBL] [Abstract][Full Text] [Related]
19. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
[TBL] [Abstract][Full Text] [Related]
20. General pharmacological properties of the human corticotropin-releasing hormone corticorelin (human).
Andoh K; Kimura T; Saeki I; Tabata R; Yamazaki S; Eguchi I; Hanazuka M; Horii D; Munt PL; Davis AS
Arzneimittelforschung; 1994 Jun; 44(6):715-26. PubMed ID: 8053970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
